Secure Your Profit Gains: Urgent Earnings Alert!

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Secret Gold Back currency RUINING Biden's plans for a digital dollar?]( [There is a secret currency that’s beginning to spread across America. Click here now for details.]( --------------------------------------------------------------- November 27, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [AI to Disrupt Energy Market (Huge Potential Gains!)]( orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… It makes them all look like small fries… In fact, just one year of this untapped resource in the USA alone provides 5X as much power as the largest oil field on Earth… And this resource is about to be unleashed on the world like never before with the help of one tiny Silicon Valley company…[Click here for all the details…]( --------------------------------------------------------------- [Nano-X Imaging]( Symbol: [NNOX]( Recent Price: $6.62 Average Analyst Price Target: $22.25 (119.03%) Market Cap: $379.28M Last Year's EPS: -$0.21 Consensus EPS Forecast: -$0.26 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: Ben Haynor, analyst at Alliance Global Partners, reiterates coverage on [Nano-X Imaging (NNOX)]( in the Healthcare sector with a Buy rating and a price target of $14.5 (2 months ago). [TipRanks.com]( also reports that [Nano-X Imaging]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $22.25 . The target pricing ranges from a high forecast of $30 down to a low forecast of $14.5. [Nano-X Imaging (NNOX)](’s last closing price was $6.62 which would put the average price target at 119.03% upside. Here are 3rd party ratings for [NNOX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 31% (77 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Top market research firm: “A Gold Storm is Coming”]( of the richest men in the world are jumping in right now. One firm says: “We are in the early stages of a mania – the calm before the storm.” --------------------------------------------------------------- [Citi Trends]( Symbol: [CTRN]( Recent Price: $26.44 Average Analyst Price Target: $30.00 (32.38%) Market Cap: $226.43M Last Year's EPS: -$0.31 Consensus EPS Forecast: -$0.94 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: John Lawrence, analyst at Benchmark Co., reiterates coverage on [Citi Trends (CTRN)]( in the Consumer Cyclical sector with a Buy rating and a price target of $35 (3 days ago). [TipRanks.com]( also reports that [Citi Trends]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $30.00 . The target pricing ranges from a high forecast of $35 down to a low forecast of $23. [Citi Trends (CTRN)](’s last closing price was $26.44 which would put the average price target at 32.38% upside. Here are 3rd party ratings for [CTRN](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Alarum Technologies]( Symbol: [ALAR]( Recent Price: $5.61 Average Analyst Price Target: $9.00 (60.43%) Market Cap: $31.21M Last Year's EPS: -$0.02 Consensus EPS Forecast: -$0.24 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: Brian Kinstlinger, analyst at Alliance Global Partners, reiterates coverage on [Alarum Technologies (ALAR)]( in the Technology sector with a Buy rating and a price target of $9 (1 month ago). [TipRanks.com]( also reports that [Alarum Technologies]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.00 . The target pricing ranges from a high forecast of $9 down to a low forecast of $9. [Alarum Technologies (ALAR)](’s last closing price was $5.61 which would put the average price target at 60.43% upside. Here are 3rd party ratings for [ALAR](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Apple to SHOCK Emerging $46T Industry]( Valley venture capitalist Luke Lango says this little-known Apple project could be 10X bigger than the iPhone, MacBook, and iPad COMBINED! Investing in Apple today would be a smart move... but he’s discovered a bigger opportunity lying under Wall Street’s radar -one that could give early investors a shot at 40X gains! [Click here for more details.]( --------------------------------------------------------------- [Canaan]( Symbol: [CAN]( Recent Price: $1.73 Average Analyst Price Target: $4.75 (131.21%) Market Cap: $294.17M Last Year's EPS: -$0.43 Consensus EPS Forecast: -$0.15 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: Kevin Dede, analyst at H.C. Wainwright, reiterates coverage on [Canaan (CAN)]( in the Technology sector with a Buy rating and a price target of $4 (2 months ago). [TipRanks.com]( also reports that [Canaan]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.75 . The target pricing ranges from a high forecast of $5.5 down to a low forecast of $4. [Canaan (CAN)](’s last closing price was $1.73 which would put the average price target at 131.21% upside. Here are 3rd party ratings for [CAN](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 19% (48 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [MYT Netherlands]( Symbol: [MYTE]( Recent Price: $3.11 Average Analyst Price Target: $5.04 (70.42%) Market Cap: ― Last Year's EPS: $0.01 Consensus EPS Forecast: $0.03 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: Geoffroy de, analyst at Bank of America Securities, reiterates coverage on [MYT Netherlands (MYTE)]( in the Consumer Cyclical sector with a Buy rating and a price target of $6.5 (5 days ago). [TipRanks.com]( also reports that [MYT Netherlands]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.04 . The target pricing ranges from a high forecast of $6.5 down to a low forecast of $4. [MYT Netherlands (MYTE)](’s last closing price was $3.11 which would put the average price target at 70.42% upside. Here are 3rd party ratings for [MYTE](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 17% (42 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Imminent FDA Decision Could End Obesity in America...]( [...and spark a 224,000% sales surge for one tiny micro-cap stock.]( The Wall Street Journal Reports: The "King Kong" of drugs is coming. Barron's Reports: "it's game changing." [Get the name of the stock here ]( --------------------------------------------------------------- [Intuit]( Symbol: [INTU]( Recent Price: $564.07 Average Analyst Price Target: $568.00 (3.58%) Market Cap: $158.09B Last Year's EPS: $8.92 Consensus EPS Forecast: $1.38 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: Mark Murphy, analyst at J.P. Morgan, reiterates coverage on [Intuit (INTU)]( in the Technology sector with a Hold rating and a price target of $470 (1 day ago). [TipRanks.com]( also reports that [Intuit]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $568.00 . The target pricing ranges from a high forecast of $605 down to a low forecast of $470. [Intuit (INTU)](’s last closing price was $564.07 which would put the average price target at 3.58% upside. Here are 3rd party ratings for [INTU](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 19% (48 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [PDD Holdings]( Symbol: [PDD]( Recent Price: $118.70 Average Analyst Price Target: $142.00 (6.88%) Market Cap: $157.70B Last Year's EPS: $1.01 Consensus EPS Forecast: $1.12 Expected Earnings Date: Nov 28 2023 Recent Analyst Action: Eddy Wang, analyst at Morgan Stanley, reiterates coverage on [PDD Holdings (PDD)]( in the Consumer Cyclical sector with a Buy rating and a price target of $140 (3 days ago). [TipRanks.com]( also reports that [PDD Holdings]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $142.00 . The target pricing ranges from a high forecast of $155 down to a low forecast of $120. [PDD Holdings (PDD)](’s last closing price was $118.70 which would put the average price target at 6.88% upside. Here are 3rd party ratings for [PDD](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 17% (42 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI's 'Next Wave' of Stocks]( AI stocks have popped this year. [Nvidia]( just became the seventh trillion-dollar company in history. The stock is up 233%. That’s just one high-profile example. C3.ai is up 352%...Opera 374%... Duos Technology Group 278%... And BigBear.ai’s stock rose 846% in less than two months. With gains like that, you might think the AI stock boom is over. But Sean Brodrick thinks it’s just getting started. [Click here to see which AI stock he believes could be next]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software